Approval · Notice of Compliance 18126 · 2016
CIPRODEX: Notice of Compliance 18126
Issued May 13, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18126
- Date
- May 13, 2016
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the inner and outer labels to comply with the requirements of plain language labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRODEX | Not yet assigned | — |
Medicinal ingredients
- DEXAMETHASONE 0.1 PER
- CIPROFLOXACIN HYDROCHLORIDE 0.3 PER